Gene
|
Condition
|
| AIP |
Pituitary adenomas |
| APC |
Colorectal, endocrine, gastric, nervous system/brain, and pancreatic cancer, sarcoma |
| ATM |
Breast, pancreatic, and prostate cancer |
| AXIN2 |
Colorectal cancer |
| BAP1 |
Renal/urinary tract cancer, melanoma |
| BARD1 |
Breast cancer |
| BMPR1A |
Colorectal, gastric, and pancreatic cancer |
| BRCA1 |
Breast, gynecologic, pancreatic, and prostate cancer |
| BRCA2 |
Breast, gynecologic, pancreatic, and prostate cancer, melanoma |
| BRIP1 |
Breast and gynecologic cancer |
| CDC73 |
Endocrine and renal/urinary tract cancer |
| CDH1 |
Breast, colorectal, and gastric cancer |
| CDK4 |
Melanoma |
| CDKN1B |
Prostate |
| CDKN2A |
Nervous system/brain and pancreatic cancer, melanoma |
| CHEK2 |
Breast, colorectal, endocrine, gynecologic, and prostate cancer |
| DICER1 |
Endocrine, gynecologic, nervous system/brain, and renal/urinary tract cancer, sarcoma |
| EGFR |
Lung cancer |
| EPCAM |
Colorectal, gastric, gynecologic, nervous system/ brain, pancreatic, prostate, and renal/urinary tract cancer |
| FH |
Renal/urinary tract cancer, sarcoma |
| FLCN |
Renal/urinary tract cancer |
| GREM1 |
Colorectal cancer |
| HOXB13 |
Prostate cancer |
| KIT |
Gastric cancer, sarcoma |
| LZTR1 |
Schwannomatosis |
| MAX |
Endorcrine cancer |
| MEN1 |
Endocrine, nervous system/brain, and pancreatic cancer |
| MET |
Renal/urinary tract cancer |
| MITF |
Melanoma |
| MLH1 |
Colorectal, gastric, gynecologic, nervous system/ brain, pancreatic, prostate, and renal/urinary tract cancer |
| MSH2 |
Colorectal, gastric, gynecologic, nervous system/ brain, pancreatic, prostate, and renal/urinary tract cancer |
| MSH3 |
Colorectal cancer, includes reporting of carrier status |
| MSH6 |
Colorectal, gastric, gynecologic, nervous system/ brain, pancreatic, prostate, and renal/urinary tract cancer |
| MUTYH |
Colorectal cancer |
| NF1 |
Breast, endocrine, gastric, and nervous system/brain cancer |
| NF2 |
Nervous system/brain cancer |
| NTHL1 |
Colorectal cancer, includes reporting of carrier status |
| PALB2 |
Breast and pancreatic cancer |
| PDGFRA |
Gastric cancer, sarcoma |
| PMS2 |
Colorectal, gastric, gynecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer |
| POLD1 |
Colorectal cancer |
| POLE |
Colorectal cancer |
| POT1 |
Melanoma, leukaemia |
| PRKAR1A |
Endocrine and nervous system/brain cancer, sarcoma |
| PTCH1 |
Nervous system/brain and skin cancer, sarcoma |
| PTEN |
Breast, colorectal, endocrine, gynecologic, nervous system/brain and, renal/urinary tract cancer, melanoma |
| RAD51C |
Breast and gynecologic cancer |
| RAD51D |
Breast and gynecologic cancer |
| RB1 |
Melanoma, retinoblastoma, sarcoma |
| RET |
Endocrine cancer |
| SDHA |
Endocrine and gastric cancer, sarcoma |
| SDHAF2 |
Endocrine cancer |
| SDHB |
Endocrine, gastric, and renal/urinary tract cancer, sarcoma |
| SDHC |
Endocrine, gastric, and renal/urinary tract cancer, sarcoma |
| SDHD |
Endocrine, gastric, and renal/urinary tract cancer, sarcoma |
| SMAD4 |
Colorectal, gastric, and pancreatic cancer |
| SMARCA4 |
Gynecologic cancer |
| SMARCB1 |
Nervous system/brain and renal/urinary tract cancer |
| STK11 |
Breast, colorectal, gastric, gynecologic, and pancreatic cancer |
| TMEM127 |
Endocrine cancer |
| TP53 |
Breast, endocrine, gastrointestinal, genitourinary, gynecologic, hematologic, nervous system/brain, and skin cancer, sarcoma |
| TSC1 |
Nervous system/brain, pancreatic, and renal/urinary tract cancer |
| TSC2 |
Nervous system/brain, pancreatic, and renal/urinary tract cancer |
| VHL |
Endocrine, nervous system/brain, pancreatic, and renal/urinary tract cancer |
| WT1 |
Renal/urinary tract cancer |